I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2026 Q2, the actual value is USD 55.2 M, missing the estimate of USD 55.39 M.
EPS: As of FY2026 Q2, the actual value is USD -0.05, beating the estimate of USD -0.0785.
EBIT: As of FY2026 Q2, the actual value is USD -6.422 M.
Second Quarter 2026 Financial Highlights
Revenue
Definitive Healthcare Corp. reported revenue of $55.2 million for the second quarter of 2026, marking a 9% decrease from $60.8 million in Q2 2025.
Net Loss
Net loss for Q2 2026 was - $7.5 million, or -14% of revenue, compared to - $9.3 million, or -15% of revenue, in Q2 2025.
Adjusted Net Income
Adjusted Net Income for Q2 2026 was $7.5 million, down from $9.7 million in Q2 2025.
Adjusted EBITDA
Adjusted EBITDA reached $14.6 million in Q2 2026, representing 26% of revenue, a decrease from $18.7 million, or 31% of revenue, in Q2 2025.
Cash Flow
Cash Flow from Operations was $11.5 million in the second quarter of 2026. Unlevered Free Cash Flow for the quarter stood at $11.6 million.
Gross Profit and Margin
GAAP gross profit was $40,541 thousand in Q2 2026, compared to $46,613 thousand in Q2 2025. The GAAP gross margin was 73% in Q2 2026, down from 77% in Q2 2025. Adjusted gross profit was $44,160 thousand (80% margin) in Q2 2026, compared to $49,981 thousand (82% margin) in Q2 2025.
Operating Expenses
Total operating expenses were $47,289 thousand in Q2 2026, a decrease from $50,783 thousand in Q2 2025. Sales and marketing expenses were $19,158 thousand in Q2 2026, compared to $20,469 thousand in Q2 2025. Product development expenses were $6,756 thousand in Q2 2026, compared to $7,968 thousand in Q2 2025. General and administrative expenses were $10,806 thousand in Q2 2026, compared to $12,673 thousand in Q2 2025. Depreciation and amortization expenses were $8,542 thousand in Q2 2026, compared to $9,001 thousand in Q2 2025. Transaction, integration, and restructuring expenses increased to $2,027 thousand in Q2 2026 from $672 thousand in Q2 2025.
Loss from Operations
Definitive Healthcare Corp. reported a loss from operations of - $6,748 thousand in Q2 2026, compared to - $4,170 thousand in Q2 2025.
Other Income/Expense and Interest
Net interest expense was - $1,375 thousand in Q2 2026, compared to - $1,241 thousand in Q2 2025. Other income, net, was $326 thousand in Q2 2026, a significant improvement from other expense, net, of - $3,398 thousand in Q2 2025.
Adjusted Operating Income
Adjusted Operating Income was $11,840 thousand for Q2 2026, down from $15,639 thousand in Q2 2025.
Investing and Financing Activities
Purchases of property, equipment, and data assets were - $2,942 thousand in Q2 2026, compared to - $2,293 thousand in Q2 2025. Repayments of the term loan were - $2,187 thousand in Q2 2026, similar to - $2,188 thousand in Q2 2025.
Business Outlook
For Q3 2026, Definitive Healthcare Corp. anticipates revenue between $54.0 million and $55.0 million, with Adjusted Operating Income projected from $10.5 million to $11.5 million, and Adjusted EBITDA from $13.5 million to $14.5 million. For the full year 2026, the company expects revenue between $220.0 million and $222.0 million, Adjusted Operating Income between $45.5 million and $47.5 million, and Adjusted EBITDA between $57.0 million and $59.0 million. Full-year Adjusted Net Income is projected to be between $27.0 million and $29.0 million, with Adjusted Net Income Per Diluted Share between $0.18 and $0.20.